Header Logo

Connection

STEPHEN PFLUGFELDER to Administration, Topical

Back to Details
This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Administration, Topical.
STEPHEN PFLUGFELDER
Connection Strength
0.800
Administration, Topical
  1. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease. JAMA Ophthalmol. 2015 Oct; 133(10):1117-23.
    View in: PubMed
    Score: 0.124
  2. Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease. Am J Ophthalmol. 2015 Jul; 160(1):135-42.e1.
    View in: PubMed
    Score: 0.120
  3. Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye. Exp Eye Res. 2014 Jan; 118:117-24.
    View in: PubMed
    Score: 0.109
  4. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009 May-Jun; 54(3):321-38.
    View in: PubMed
    Score: 0.079
  5. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. Eye Contact Lens. 2006 Dec; 32(6):272-6.
    View in: PubMed
    Score: 0.067
  6. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005 Jan; 24(1):80-5.
    View in: PubMed
    Score: 0.059
  7. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001 Jul; 132(1):8-13.
    View in: PubMed
    Score: 0.046
  8. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj?gren syndrome. Ophthalmology. 1999 Apr; 106(4):811-6.
    View in: PubMed
    Score: 0.039
  9. Nasolacrimal stimulation of aqueous tear production. Cornea. 1997 Nov; 16(6):645-8.
    View in: PubMed
    Score: 0.036
  10. Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye. PLoS One. 2015; 10(9):e0138958.
    View in: PubMed
    Score: 0.031
  11. Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model. Invest Ophthalmol Vis Sci. 2015 Sep; 56(10):5888-95.
    View in: PubMed
    Score: 0.031
  12. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea. 2012 Nov; 31(11):1299-303.
    View in: PubMed
    Score: 0.025
  13. Complications of intraocular antimicrobial agents. Int Ophthalmol Clin. 1989; 29(3):188-94.
    View in: PubMed
    Score: 0.019
  14. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000 Jul; 19(4):492-6.
    View in: PubMed
    Score: 0.011
  15. Topical anesthetic abuse. Ophthalmology. 1990 Aug; 97(8):967-72.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.